Fundraising Fox

Complexa

Pittsburgh, US · Founded 2012 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

JM
Joshua M. TarnoffExecutive
DJ
Diane JorkaskyChief Medical Officer
FO
Federica O'BrienChief Financial Officer
HH
Hironori HozojiNamed on SEC filing

Board

IW
I. Wistar MorrisBoard director
KH
Kenji HaradaBoard director
MT
Miwa ToyodaBoard director
CM
Carter MeyerBoard director
HJ
H. Joseph ReiserBoard director
PG
Peter GrebowBoard director

Investors · 3

Andera PartnersParis
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Pfizer Venture Investments$5M – $20M

Reported raises · per SEC filings

Form D private placements

$72.3M disclosed across 6 rounds · 2014–2019

▶$11MraisedApr 2019 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara DaltonDirector
  • Francisco D. SalvaExecutive Officer, Director
  • Kenji HaradaDirector
  • I. Wistar MorrisDirector
  • Gilles NobecourtDirector
  • David MottDirector
  • Sara M. NayeemDirector
  • Bernardus N. MachielseDirector
Offering amount
$28M
Amount sold
$11M
Proceeds to insiders
$302K
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedJul 2017 · 28 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • I. Wistar MorrisDirector
  • David MottDirector
  • Diane JorkaskyExecutive Officer
  • Sara NayeemDirector
  • Kenji HaradaDirector
  • Federica O'BrienExecutive Officer
  • Gilles NobecourtDirector
  • Barbara DaltonDirector
  • Joshua M. TarnoffExecutive Officer, Director
Offering amount
$62.6M
Amount sold
$40.6M
Sales commissions
$1.8M
Proceeds to insiders
$1.5M
Placement agents
Wedbush Securities Inc.
First sale
Jul 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedNov 2016 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • H. Joseph ReiserDirector
  • Kenji HaradaDirector
  • Carter MeyerDirector
  • Miwa ToyodaDirector
  • Diane JorkaskyExecutive Officer
  • Federica O'BrienExecutive Officer
  • I. Wistar MorrisDirector
  • Peter GrebowDirector
  • Joshua M. TarnoffExecutive Officer, Director
Offering amount
$1.4M
Amount sold
$1M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$950KraisedApr 2016 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • I. Wistar MorrisDirector
  • Carter MeyerDirector
  • Miwa ToyodaDirector
  • Frederica O'BrienExecutive Officer
  • Kenji HaradaDirector
  • Joshua M. TarnoffExecutive Officer, Director
  • Peter GrebowDirector
  • H. Joseph ReiserDirector
  • Diane JorkaskyExecutive Officer
Offering amount
$2M
Amount sold
$950K
Proceeds to insiders
$169K
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJun 2015 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua M. TarnoffExecutive Officer, Director
  • I. Wistar MorrisDirector
  • H. Joseph ReiserDirector
  • Kenji HaradaDirector
  • Miwa ToyodaDirector
  • Diane JorkaskyExecutive Officer
  • Federica O'BrienExecutive Officer
  • Peter GrebowDirector
  • Carter MeyerDirector
Offering amount
$5M
Amount sold
$4M
Proceeds to insiders
$500K
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.8MraisedJun 2014 · 28 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter GrebowDirector
  • Joshua M. TarnoffExecutive Officer, Director
  • Hironori HozojiDirector
  • H. Joseph ReiserDirector
  • I. Wistar MorrisDirector
  • Kenji HaradaDirector
  • Carter MeyerDirector
Offering amount
$14.8M
Amount sold
$14.8M
Minimum investment
$10.3K
Sales commissions
$240K
Proceeds to insiders
$1.4M
Placement agents
Middlebury Securities, LLC
First sale
May 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Complexa's investors?
Complexa's investors include Andera Partners, New Enterprise Associates (NEA), Pfizer Venture Investments.
How much funding has Complexa raised?
Complexa has disclosed $72.3M raised across 6 rounds.
Where is Complexa headquartered?
Complexa is headquartered in Pittsburgh, US.